CheckMyRecalls

Baxter Healthcare Corporation recalls Cefazolin in Dextrose

Published
19 Aug 2026
Units affected
19,032 bags
Agency
FDA
Country
United States

The hazard

Presence of Particulate Matter

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Brand / company
Baxter Healthcare Corporation
Codes / lots
Lot # LD175708, Exp Date: 14-Feb-2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 19 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.